Join
Live feed
·
INSIDERFilingvia Quantisnow
Lixte Biotechnology Holdings Inc. logo

CEO and Chairman of the Board Pursglove Geordan Garrett was granted 350,000 shares, increasing direct ownership by 100% to 700,000 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
LIXT· Lixte Biotechnology Holdings Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LIXT (Lixte Biotechnology Holdings Inc.) and more on Quantisnow.